$6.50
$0.02
(0.31%)
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
Related Resources
NBIX
vs. S&P 500
|
$6.50
$0.02
(0.31%)
|
|
| Today's Open | $6.46 |
|---|---|
| Previous Close | $6.48 |
| Daily Range | $6.41 - $6.60 |
| 52-Week Range | $5.42 - $9.98 |
| Market Cap | $431.0M |
| P/E Ratio | 10.66 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 328,732 |
| Average Daily Volume | 397,375 |
| Current FY EPS | -$0.18 |
Sector
Healthcare
Industry
Biotechnology
Description
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.
